The Original Investigation titled “Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: the NRG-GU003 Phase 3 Randomized Clinical Trial,”1 published online March 14, 2024, contained an error in the y-axis of Figure 2. The correct measurement is the percentage of patients with grade 3 or higher adverse events. This article was corrected online.
1.Buyyounouski
MK, Pugh
SL, Chen
RC,
et al. Noninferiority of hypofractionated vs conventional postprostatectomy radiotherapy for genitourinary and gastrointestinal symptoms: the NRG-GU003 phase 3 randomized clinical trial. JAMA Oncol. Published online March 14, 2024. doi: